LumaSon .19 mg/mg
SULFUR HEXAFLUORIDE · INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION · BRACCO DIAGNOSTICS INC
LumaSon is a injection, powder, lyophilized, for suspension containing sulfur hexafluoride at .19 mg/mg, taken intravenous. Manufactured by BRACCO DIAGNOSTICS INC.
Key Facts
- Brand Name
- LumaSon
- Generic Name
- SULFUR HEXAFLUORIDE
- NDC Code (Product)
0270-7097- Manufacturer
- BRACCO DIAGNOSTICS INC
- Strength
- .19 mg/mg
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
- Route
- INTRAVENOUS, INTRAVESICAL
- Marketing Status
- Application #
- NDA203684
- Drug Class
- Contrast Agent for Ultrasound Imaging [EPC]
- Marketing Start
- 04/01/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is LumaSon used for?
LumaSon contains SULFUR HEXAFLUORIDE. It is a injection, powder, lyophilized, for suspension taken intravenous. Consult your doctor for specific uses.
Is LumaSon a controlled substance?
LumaSon is not classified as a controlled substance by the DEA.
What is the generic name for LumaSon?
The generic name for LumaSon is SULFUR HEXAFLUORIDE. There are no other listed brand versions of SULFUR HEXAFLUORIDE.
What is the NDC code for LumaSon .19 mg/mg?
The NDC (National Drug Code) for LumaSon .19 mg/mg is 0270-7097, listed by BRACCO DIAGNOSTICS INC.
Other LumaSon Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)